YTHDF1 Promotes Breast Cancer Cell Growth, DNA Damage Repair, and Chemoresistance

YTHDF1 facilitated S-phase entry, DNA replication and DNA damage repair, and accordingly YTHDF1 knockdown sensitized breast cancer cells to Adriamycin and Cisplatin as well as Olaparib, a PARP inhibitor.